TSH Biopharm Corporation Limited (TPEX:8432)
Taiwan · Delayed Price · Currency is TWD 48.80
0.00 (0.00%)
Jul 30, 2026, 1:30 PM CST
TSH Biopharm Corporation Market Cap
TSH Biopharm Corporation has a market cap or net worth of 1.87 billion as of July 29, 2026. Its market cap has increased by 1.88% in one year.
Market Cap
1.87B
Enterprise Value
1.10B
Revenue
1.34B
Ranking
n/a
PE Ratio
12.71
Stock Price
48.80
ChartMarket Cap Chart
Since June 16, 2011, TSH Biopharm Corporation's market cap has decreased from 1.96B to 1.87B, a decrease of -4.51%. That is a compound annual growth rate of -0.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 1.87B | -16.58% |
| Dec 31, 2025 | 2.25B | -4.57% |
| Dec 31, 2024 | 2.35B | 21.87% |
| Dec 29, 2023 | 1.93B | 5.78% |
| Dec 30, 2022 | 1.83B | 6.85% |
| Dec 30, 2021 | 1.71B | -24.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tien Liang BioTech | 3.39B |
| Yoda Pharmaceuticals | 3.04B |
| Maywufa Company | 2.74B |
| Johnson Chemical Pharmaceutical Works | 2.34B |
| Allied Biotech | 2.32B |
| Merdury Biopharmaceutical | 2.29B |
| PhytoHealth | 2.26B |
| GeneFerm Biotechnology | 1.26B |